Literature DB >> 22750066

Caffeine increases psychomotor performance on the effort expenditure for rewards task.

Margaret C Wardle1, Michael T Treadway, Harriet de Wit.   

Abstract

Preclinical studies suggest that cost/benefit decision-making involves interactions between adenosine and dopamine (DA). In rats, DA depletion decreases willingness to incur effort costs, while adenosine antagonism reverses these effects, likely by increasing DA transmission. Caffeine is a non-selective adenosine antagonist commonly used to facilitate effortful tasks, and thus may affect decisions involving effort costs in humans. The current study examined acute effects of 200 mg of caffeine on willingness to exert effort for monetary rewards at varying levels of reward value and reward probability, in young adult light caffeine users. Based on previous findings with amphetamine, we predicted that caffeine would increase willingness to exert effort. At separate sessions, 23 healthy normal adults received placebo or 200 mg caffeine under counterbalanced double-blind conditions, then completed the effort expenditure for rewards task (EEfRT). Measures of subjective and cardiovascular effects were obtained at regular intervals. Caffeine produced small but significant subjective and cardiovascular effects, and sped psychomotor performance on the EEfRT. Caffeine did not alter willingness to exert effort, except in high cardiovascular responders to caffeine, in whom it decreased willingness to exert effort. These results were contrary to our predictions, but consistent with rodent studies suggesting that moderate doses of caffeine alone do not affect effort, but rather only influence effort in the context of DA antagonism. Our results demonstrate that psychomotor speeding and decisional effects on the EEfRT are dissociable, providing additional evidence for the EEfRT as a specific measure of effort-based decision-making. This study provides a starting point for exploring contributions of the adenosine system to motivation in humans.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750066      PMCID: PMC3578395          DOI: 10.1016/j.pbb.2012.06.016

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  33 in total

1.  Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors.

Authors:  J F Chen; M Beilstein; Y H Xu; T J Turner; R Moratalla; D G Standaert; V J Aloyo; J S Fink; M A Schwarzschild
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 2.  Effects of caffeine ingestion on rating of perceived exertion during and after exercise: a meta-analysis.

Authors:  M Doherty; P M Smith
Journal:  Scand J Med Sci Sports       Date:  2005-04       Impact factor: 4.221

Review 3.  Utility of subjective-effects measurements in assessing abuse liability of drugs in humans.

Authors:  M W Fischman; R W Foltin
Journal:  Br J Addict       Date:  1991-12

4.  Absorption and subjective effects of caffeine from coffee, cola and capsules.

Authors:  A Liguori; J R Hughes; J A Grass
Journal:  Pharmacol Biochem Behav       Date:  1997-11       Impact factor: 3.533

5.  Absorption rate of methylxanthines following capsules, cola and chocolate.

Authors:  G K Mumford; N L Benowitz; S M Evans; B J Kaminski; K L Preston; C A Sannerud; K Silverman; R R Griffiths
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

6.  The interactive effect of personality, time of day, and caffeine: a test of the arousal model.

Authors:  W Revelle; M S Humphreys; L Simon; K Gilliland
Journal:  J Exp Psychol Gen       Date:  1980-03

7.  Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.

Authors:  Marzena Karcz-Kubicha; Katerina Antoniou; Anton Terasmaa; Davide Quarta; Marcello Solinas; Zuzana Justinova; Antonella Pezzola; Rosaria Reggio; Christa E Müller; Kjell Fuxe; Steven R Goldberg; Patrizia Popoli; Sergi Ferré
Journal:  Neuropsychopharmacology       Date:  2003-04-09       Impact factor: 7.853

8.  Nucleus accumbens dopamine release increases during instrumental lever pressing for food but not free food consumption.

Authors:  J D Salamone; M S Cousins; L D McCullough; D L Carriero; R J Berkowitz
Journal:  Pharmacol Biochem Behav       Date:  1994-09       Impact factor: 3.533

Review 9.  Caffeine consumption.

Authors:  J J Barone; H R Roberts
Journal:  Food Chem Toxicol       Date:  1996-01       Impact factor: 6.023

View more
  8 in total

1.  Examining the reliability and validity of two versions of the Effort-Expenditure for Rewards Task (EEfRT).

Authors:  Hanno Andreas Ohmann; Niclas Kuper; Jan Wacker
Journal:  PLoS One       Date:  2022-01-28       Impact factor: 3.240

2.  Does Tobacco Abstinence Decrease Reward Sensitivity? A Human Laboratory Test.

Authors:  John R Hughes; Alan J Budney; Sharon R Muellers; Dustin C Lee; Peter W Callas; Stacey C Sigmon; James R Fingar; Jeff Priest
Journal:  Nicotine Tob Res       Date:  2017-06-01       Impact factor: 4.244

3.  Comparison of Caffeine and d-amphetamine in Cocaine-Dependent Subjects: Differential Outcomes on Subjective and Cardiovascular Effects, Reward Learning, and Salivary Paraxanthine.

Authors:  Scott D Lane; Charles E Green; Joy M Schmitz; Nuvan Rathnayaka; Wendy B Fang; Sergi Ferré; F Gerard Moeller
Journal:  J Addict Res Ther       Date:  2014

Review 4.  Molecular and pharmacodynamic interactions between caffeine and dopaminergic system.

Authors:  M Voiculescu; I Ghiță; A Segărceanu; I Fulga; O Coman
Journal:  J Med Life       Date:  2014

Review 5.  Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.

Authors:  Laura López-Cruz; John D Salamone; Mercè Correa
Journal:  Front Pharmacol       Date:  2018-06-01       Impact factor: 5.810

6.  Pharmacological investigations of effort-based decision-making in humans: Naltrexone and nicotine.

Authors:  Cecilia Nunez; Jennifer K Hoots; Scott T Schepers; Michael Bower; Harriet de Wit; Margaret C Wardle
Journal:  PLoS One       Date:  2022-10-05       Impact factor: 3.752

7.  Is it Worth the Effort? Novel Insights into Obesity-Associated Alterations in Cost-Benefit Decision-Making.

Authors:  David Mathar; Annette Horstmann; Burkhard Pleger; Arno Villringer; Jane Neumann
Journal:  Front Behav Neurosci       Date:  2016-01-12       Impact factor: 3.558

8.  Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women.

Authors:  Margaret C Wardle; Elisa Pabon; Heather E Webber; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2022-02-01       Impact factor: 4.415

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.